发明名称 Controlled modulation of amino acid side chain length of peptide antigens
摘要 The invention provides a method for the creation of peptide antigens comprising epitopes with at least a first modification comprising a shortened or lengthened amino acid side chain. By extension or shortening of the side chain with CH3/CH2 groups, for example, made by computer assisted modeling of the tumor antigen (peptide) bound in the MHC-I-groove, immunogenicity can be improved with minimal modification of adjacent tertiary structure, thereby avoiding cross-reactivity. Provided by the invention are methods of creating such antigens, as well as methods for therapeutic or prophylactic treatment of various conditions comprising administration of the antigens.
申请公布号 US8802618(B2) 申请公布日期 2014.08.12
申请号 US200310507009 申请日期 2003.03.06
申请人 Board of Regents, The University of Texas System;Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. 发明人 Ioannides Constantin G.;Campbell Martin L.;O'Brian Catherine A.;Peoples George E.
分类号 A61K31/00;A61K35/00;A61K38/08;A61K39/00 主分类号 A61K31/00
代理机构 Parker Highlander PLLC 代理人 Parker Highlander PLLC
主权项 1. A method for preparing a composition comprising an immunogenic cytotoxic T lymphocyte (CTL) peptide antigen, the method comprising: a) providing an immunogenic CTL peptide antigen comprising a modified E75 CTL epitope, wherein the modified E75 CTL epitope has the amino acid sequence of SEQ ID NO:2 with a α-aminobutyric acid, norvaline or norleucine at position 4, a α-aminobutyric acid, norvaline or norleucine at position 7 or an isophenylalanine at position 8 of SEQ ID NO:2; and b) formulating the peptide antigen with a pharmaceutically acceptable carrier.
地址 Austin TX US